: iStockAnalyst.com Symbols Feed

Market Commentary (02-02-09)

Tue, 03 Feb 2009 13:28:00 GMT

Bloomberg had this article out about how the U.S. housing market lost $3.3 trillion in 2008 AND that 1 in 6 people with mortgages are underwater, or 17%. It's not getting any better. We have pending home sales coming out today at 10:00AM - consensus 82.3 (range: 78.2 to 84, previous actual: 82.3). I'll be really surprised if pending sales remained "unchanged". Motor vehicle sales are also coming out (total consensus: 7.7M (range:7.3M to 8.1M, previous actual: 7.7M). This is another consensus estimate where it is also "unchanged". Whatever. You see, [More...]

Retail Clinics Showing Good Performance

Mon, 26 May 2008 18:22:15 GMT

NEW YORK (UPI)...[More...]

Uroplasty Reports First Fiscal Quarter Results

Mon, 03 Aug 2009 20:01:00 GMT

Uroplasty Reports First Fiscal Quarter Results ; - Macroplastique(R) Year-Over-Year U.S. Sales Double -; - SUmiT Trial Nears Completion -; - Conference Call to Be Held Today at 3:30 PM Central Time -

Mon, 03 Aug 2009 17:45:00 GMT

MINNEAPOLIS, Aug. 3 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (NYSE Amex: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today reported financial results for the first fiscal quarter ended June 30, 2009.
"While our fiscal first quarter financial performance is below year-ago results, we are encouraged by our U.S. Macroplastique sales that have doubled from last year's fiscal first quarter.
Fiscal First Quarter Results for the Period Ended June 30, 2009

[More...]

Uroplasty to Issue First Fiscal Quarter Results on August 3, 2009

Mon, 27 Jul 2009 10:26:00 GMT

Uroplasty, Inc. announced today that it will release financial results for the first fiscal quarter ended June 30, 2009, at the market close on Monday, August 3, 2009. The Company will host a conference call to discuss these results on Monday, August 3, 2009 at 3:30 p.m. Central Time. David Kaysen, President and Chief Executive Officer, and Medi Jiwani, Vice President, Chief Financial Officer and Treasurer, will host the call. Individuals wishing to participate in the conference call should dial 877-941-1466 or 480-629-9644 . An audio replay will be available for 30 days following the call at 800-406-7325 or 303-590-3030 , with the passcode 4119644 #.[More...]

Uroplasty Announces Patent Issuance Related to the Urgent(R) PC System

Mon, 13 Jul 2009 10:25:00 GMT

Uroplasty, Inc. , a medical device company that develops, manufactures and markets innovative proprietary products for the treatment of voiding dysfunctions, announced today the issuance of United States Patent No. 7,536,226 entitled, "Electro-Nerve Stimulator System and Methods." The patent covers the company's Urgent PC system and stimulation methods for treatment of the overactive bladder symptoms of urinary urgency, urge incontinence and frequency of urinary voids.[More...]

Urgent(R) PC and Macroplastique(R) Featured in Numerous IUGA 2009 Sessions

Tue, 07 Jul 2009 10:25:00 GMT

Uroplasty, Inc. , a medical device company developing, manufacturing and marketing innovative proprietary products for the treatment of voiding dysfunctions, highlighted today presentations, workshops and posters focusing on its solutions at the 34th Annual Meeting of the International Urogynecological Association , June 16-20 in Como, Italy.[More...]

Uroplasty Reports Fourth Quarter and Full Year Fiscal 2009 Results

Thu, 04 Jun 2009 20:49:00 GMT

FY 2009 U.S. Sales Up 191% -
MINNEAPOLIS, June 4 /PRNewswire-FirstCall/ -- Uroplasty, Inc. (Amex: UPI), a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today reported financial results for the fourth quarter and full year ended March 31, 2009.
"Our fourth quarter and full year results reflect the challenging environment for our Urgent PC(R) system due to insurance reimbursement uncertainties in the U.S. market," said David Kaysen, President and CEO.

[More...]

Uroplasty to Issue Fourth Fiscal Quarter and Full Year Results on June 4, 2009

Tue, 19 May 2009 10:25:00 GMT

Uroplasty, Inc. announced today that it will release financial results for the fourth fiscal quarter and full year ended March 31, 2009, at the market close on Thursday, June 4, 2009. The Company will host a conference call to discuss these results on Thursday, June 4, 2009 at 3:30 p.m. Central Time. David Kaysen, President and Chief Executive Officer, and Medi Jiwani, Vice President, Chief Financial Officer and Treasurer, will host the call. Individuals wishing to participate in the conference call should dial 877-941-8609 or 480-629-9818 . An audio replay will be available for 30 days following the call at 800-406-7325 or 303-590-3030 , with the passcode 4081844 #.[More...]

Uroplasty Reports Third Quarter Fiscal 2009 Results

Tue, 03 Feb 2009 19:56:00 GMT

Uroplasty, Inc. , a medical device company that develops, manufactures and markets innovative proprietary products to treat voiding dysfunctions, today reported financial results for the third quarter of fiscal 2009 ended December 31, 2008. Net sales for the third quarter of fiscal 2009 were $3.4 million versus $3.7 million during last fiscal year's third quarter.[More...]

Uroplasty to Host Third Fiscal Quarter Conference Call on February 3

Wed, 28 Jan 2009 10:25:00 GMT

Uroplasty, Inc. announced today that it will release financial results for the third fiscal quarter ended December 31, 2008, at the market close on Tuesday, February 3, 2009. The Company will host a conference call to discuss these results on Tuesday, February 3, 2009 at 3:30 p.m. Central Time. David Kaysen, President and Chief Executive Officer, and Medi Jiwani, Vice President, Chief Financial Officer and Treasurer, will host the call. Individuals wishing to participate in the conference call should dial 800-218-0713 or 303-262-2140 . An audio replay will be available for 30 days following the call at 800-405-2236 or 303-590-3000 , with the passcode 11123736 #.[More...]